Cardiac Rhythm Management Devices – Market Insights – Asia Pacific

The COVID-19 global pandemic will have a significant impact on the Asia Pacific CRM device market in the short term, resulting in lost procedure volumes; however, following a period of recovery, the market will grow through 2030 driven primarily by an aging population, the increasing prevalence of sedentary lifestyles and unhealthy diets, and the introduction of more advanced technology. The uptake of premium-priced devices such as MRI-conditional devices, leadless pacemakers, and S-ICDs will also boost revenues.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for CRM device in the Asia Pacific region across an 11-year period.

The CRM device market will show modest growth through 2030.

How does new technology influence growth in different product segments?

What factors will create pricing pressures, and to what extent will price erosion impact market growth?

The COVID-19 global pandemic will have a negative impact on the CRM market in the short-term.

What factors will contribute to the impact on the CRM device market?

To what degree will the pandemic affect different CRM device segments?

What impact has the pandemic had on ongoing clinical trials?

How soon will procedure volumes, sales, and revenues recover?

How has the pandemic impacted the adoption of new, innovative technologies such as leadless pacemakers?

Premium-priced device adoption will rise in the Asia Pacific region; however, it could take some time for price-conscious countries to adopt these devices.

What is the predicted uptake of novel devices such as leadless pacemakers and S-ICDs? Will leadless pacemakers and S-ICDs become the standard of care?

How does the success of a company’s ICM device affect sales of other CRM devices? Will the next-generation ICMs offered by other companies be able to compete with Medtronic’s first-mover advantage in this segment?

Manufacturers are seeking opportunities to expand their presence in the Asia Pacific countries.

Have any advanced products been approved in the market?

Have any new competitors entered into the market?

Table of contents

Cardiac Rhythm Management Devices - Market Insights - Asia Pacific

Suraj Nair, Masters in Bioprocess Technology

Suraj Nair is a Research Associate within the Cardiovascular Medtech Insights team at Decision Resources Group, specializing in the Electrophysiology Mapping and Ablation Devices Market. Suraj holds a Master’s degree in Bioprocess Technology from the Institute of Chemical Technology, Mumbai and has a prior experience of working in the biopharmaceutical industry for two years and in the market research industry for medical devices for a year.

Contact sales Login to access report

Back to all Medtech Insights reports